eCite Digital Repository
Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma
Citation
Tsai, HE and Wu, JC and Kung, ML and Liu, LF and Kuo, LH and Kuo, HM and Chen, SC and Chan, EC and Wu, CS and Tai, MH and Liu, GS, Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma, PLoS One, 8, (3) Article e59345. ISSN 1932-6203 (2013) [Refereed Article]
 | PDF 447Kb |
Copyright Statement
Copyright 2013 Tsai et al. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/
DOI: doi:10.1371/journal.pone.0059345
Abstract
Cutaneous malignant melanoma is the fastest increasing malignancy in humans. Hepatoma-derived growth factor (HDGF) is a novel growth factor identified from human hepatoma cell line. HDGF overexpression is correlated with poor prognosis in various types of cancer including melanoma. However, the underlying mechanism of HDGF overexpression in developing melanoma remains unclear. In this study, human melanoma cell lines (A375, A2058, MEL-RM and MM200) showed higher levels of HDGF gene expression, whereas human epidermal melanocytes (HEMn) expressed less. Exogenous application of HDGF stimulated colony formation and invasion of human melanoma cells. Moreover, HDGF overexpression stimulated the degree of invasion and colony formation of B16-F10 melanoma cells whereas HDGF knockdown exerted opposite effects in vitro. To evaluate the effects of HDGF on tumour growth and metastasis in vivo, syngeneic mouse melanoma and metastatic melanoma models were performed by manipulating the gene expression of HDGF in melanoma cells. It was found that mice injected with HDGF-overexpressing melanoma cells had greater tumour growth and higher metastatic capability. In contrast, mice implanted with HDGF-depleted melanoma cells exhibited reduced tumor burden and lung metastasis. Histological analysis of excised tumors revealed higher degree of cell proliferation and neovascularization in HDGF-overexpressing melanoma. The present study provides evidence that HDGF promotes tumor progression of melanoma and targeting HDGF may constitute a novel strategy for the treatment of melanoma.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Medical biotechnology |
| Research Field: | Gene and molecular therapy |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Liu, GS (Associate Professor Guei-Sheung Liu) |
| ID Code: | 120805 |
| Year Published: | 2013 |
| Web of Science® Times Cited: | 13 |
| Deposited By: | Menzies Institute for Medical Research |
| Deposited On: | 2017-08-30 |
| Last Modified: | 2018-03-16 |
| Downloads: | 94 View Download Statistics |
Repository Staff Only: item control page